PGE synthase

PGE synthase

It is known that PGE synthase, also known as prostaglandin E synthase, is made up of a group of at least three structurally and biologically distinct enzymes. PGE synthase converts prostaglandin H2 (PGH2), which is produced by cyclooxygenase (COX), to PGE2. PGES that are associated with membranes include mPGES-1, mPGES-2, and cytosolic PGES (cPGES).

Perinuclear mPGES-1 is a protein that, like COX-2, is markedly upregulated by proinflammatory stimuli and downregulated by anti-inflammatory glucocorticoids. It has a clear functional preference for COX-2 over COX-1. The Golgi membrane-associated protein mPGES-2 is synthesized, and the N-terminal hydrophobic domain is removed by proteolysis to create a mature cytosolic enzyme. This enzyme is functionally coupled with both COX-1 and COX-2 and is expressed rather constitutively in a variety of cells and tissues. cPGES is functionally linked to COX-1 to encourage immediate PGE2 production, and it is constitutively expressed in a wide range of cell types.

PGE synthase related products

Structure Cat No. Product Name CAS No. Product Description
V74281 BRP-201 2227434-74-2 BRP-201 is considered a promising research target for next-generation anti-inflammatory drugs to study inflammatory diseases and is a new, potent and specific inhibitor of mPGES-1 with IC50 of 0.42 μM.
V74282 Clopirac 42779-82-8 Clopirac is a potent and orally bioactive prostaglandin synthetase inhibitor.
V33842 Dehydroevodiamine hydrochloride 111664-82-5 Dehydroevodiamine hydrochloride, the hydrochloride salt of dehydroevodiamine, is a naturally occurring quinazoline alkaloid isolated from the unripe fruit of Evodia rutaecarpa (Rutaceae) with a variety of biological effects such as hypotensive, negative chronotropic, ion channel depressa.
V74278 Friluglanstat 1422203-86-8 Friluglanstat is a prostaglandin E synthase (mPGES-1) inhibitor (antagonist) with anti~inflammatory activity.
V2882 HPGDS inhibitor 1 1033836-12-2 HPGDS Inhibitor I (also known as H-PGDS inhibitor 1) is a novel, orally bioavailable, potent and selective inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS) with IC50 Value of 0.7 nM.
V31708 HPGDS inhibitor 2 2101626-26-8 HPGDS inhibitor 2 (GSK2894631A) is a novel, potent, highly potent and selective hematopoietic prostaglandin D synthase (H-PGDS) inhibitor with an IC50 of 9.9 nM.
V4638 limaprost 74397-12-9 Limaprost (formerly ONO1206; OP1206; ONO-1206; OP-1206) is, an alprostadil (prostaglandin E1) analogue, is a novel and potent vasodilator that increases blood flow and inhibits platelet aggregation.
V74284 Limaprost-d3 (Limaprost d3) 1263190-37-9 Limaprost-d3 is the deuterium labelled form of Limaprost.
V20408 MF-63 892549-43-8 MF-63 is a novel and selective mPGES-1 inhibitor.
V74283 mPGES-1-IN-1 2914158-00-0 MPGES-1 is considered a promising research target for next-generation anti-inflammatory drugs to study inflammatory diseases, and the IC50 of mPGES-1-IN-1 is 0.03 μM.
V14333 SAR191801 1234708-04-3 SAR191801 (hPGDS-IN-1) is a novel, potent and selecive hPGDS inhibitorwith an IC50 of 12 nM in the Fluorescence Polarization Assay (the EIA assay).
V31351 Sinensetin 2306-27-6 Sinensetin is a methylated flavonoid found in fruits that has strong anti-vascular and anti~inflammatory properties.
V76382 UT-11 UT-11 is a potent, brain-penetrating microsomal prostaglandin E synthetase-1 (mPGES-1) inhibitor that can suppress PGE2 expression in human (SK-N-AS) and mouse (BV2) cells.
V74279 Zaloglanstat (ISC-27864; GRC-27864) 1513852-12-4 Zaloglanstat (ISC-27864) is an inhibitor (blocker/antagonist) of mPGES-1 and may be utilized in research on asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain, and neurodegenerative diseases.
V29803 Zomepirac sodium salt 64092-48-4 Zomepirac sodium salt (McN-2783-21-98) is a potent inhibitor of prostaglandin biosynthesis.
Contact Us Back to top